Covered recipient · General Payments record
ORRIN K MCLEOD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,957.96
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,245.51 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $272.58 | 2 |
| SHIELD THERAPEUTICS INC | $249.98 | 2 |
| ABBVIE INC. | $200.07 | 6 |
| Amgen Inc. | $192.02 | 12 |
| Lilly USA, LLC | $132.56 | 2 |
| Axsome Therapeutics, Inc. | $124.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.80 | 1 |
| ALK-Abello, Inc | $18.09 | 1 |
| GlaxoSmithKline, LLC. | $16.25 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $122.14 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008201 | CMS |
| ABBVIE INC. | $24.24 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008203 | CMS |
| ABBVIE INC. | $9.74 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008205 | CMS |
| ABBVIE INC. | $22.98 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008207 | CMS |
| ABBVIE INC. | $4.78 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008209 | CMS |
| ABBVIE INC. | $16.19 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008211 | CMS |
| ALK-Abello, Inc | $18.09 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099893179 | CMS |
| Amgen Inc. | $10.78 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626384 | CMS |
| Amgen Inc. | $18.89 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626386 | CMS |
| Amgen Inc. | $18.50 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626388 | CMS |
| Amgen Inc. | $6.77 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626390 | CMS |
| Amgen Inc. | $22.54 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626392 | CMS |
| Amgen Inc. | $20.98 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626394 | CMS |
| Amgen Inc. | $7.40 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626396 | CMS |
| Amgen Inc. | $19.64 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626398 | CMS |
| Amgen Inc. | $21.53 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626400 | CMS |
| Amgen Inc. | $15.62 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626402 | CMS |
| Amgen Inc. | $9.03 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626404 | CMS |
| Amgen Inc. | $20.34 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626406 | CMS |
| AstraZeneca Pharmaceuticals LP | $147.58 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104247419 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104626354 | CMS |
| Axsome Therapeutics, Inc. | $124.99 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148309538 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.80 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118256350 | CMS |
| GlaxoSmithKline, LLC. | $16.25 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115764553 | CMS |
| Lilly USA, LLC | $15.15 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135301927 | CMS |
| Lilly USA, LLC | $117.41 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135255545 | CMS |
| Novartis Pharmaceuticals Corporation | $16.17 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087140432 | CMS |
| SHIELD THERAPEUTICS INC | $124.99 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150121665 | CMS |
| SHIELD THERAPEUTICS INC | $124.99 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150121667 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.